Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2021, Vol. 17 ›› Issue (04): 488 -491. doi: 10.3877/cma.j.issn.1673-5250.2021.04.017

Review

Relationship between gut microbiota and female reproductive endocrine diseases

Biyun Zhang1,1, Xiaomin Xiao2,2,(), Xingming Zhong3,3, Zhulin Miao3,3, Leilei Li1,1, Liyan Huang1,1   

  • Received:2021-01-07 Revised:2021-06-09 Published:2021-08-01
  • Corresponding author: Xiaomin Xiao
  • Supported by:
    Natural Science Foundation of Guangdong Province(2016A030313760); Guangzhou Science and Technology Planning Project(201510010253)

The gut microbiota, host and environment are closely related and constitute a balanced intestinal micro-ecosystem, and gut microbiota is involved in several of physiological functions of the host. The structural balance of gut microbiota plays an important role in nervous system, neuroendocrine and other systemic diseases of the host. However, in the field of reproductive endocrinology, studies on gut microbiota are still in the preliminary stage. Previous findings have shown that gut microbiota disorder is involved in the onset, development and regression of several reproductive endocrine system-related diseases. Gut microbiota disorder is associated with polycystic ovary syndrome (PCOS), endometriosis, and vaginal endoenvironment. Therefore, the regulation of gut microbiota has positive implications for the treatment of diseases related to the female reproductive endocrine system. The author intends to explore the relationship and the mechanism between gut microbiota and common reproductive endocrine diseases.

[1]
Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome[J]. Nature, 2011, 473(7346): 174-180. DOI: 10.1038/nature09944.
[2]
Gorjifard S, Goldszmid RS. Microbiota-myeloid cell crosstalk beyond the gut[J]. J Leukoc Biol, 2016, 100(5): 865-879. DOI: 10.1189/jlb.3RI0516-222R.
[3]
Ahmed S, Macfarlane GT, Fite A, et al. Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples[J]. Appl Environ Microbiol, 2007, 73(22): 7435-7442. DOI: 10.1128/AEM.01143-07.
[4]
Belizário JE, Faintuch J, Garay-Malpartida M. Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases[J]. Mediators Inflamm, 2018, 2018: 2037838. DOI: 10.1155/2018/2037838.
[5]
Gholizadeh P, Mahallei M, Pormohammad A, et al. Microbial balance in the intestinal microbiota and its association with diabetes, obesity and allergic disease[J]. Microb Pathog, 2019, 127: 48-55. DOI: 10.1016/j.micpath.2018.11.031.
[6]
李小芳,李秀莹,林辉瑞,等. 多囊卵巢综合征相关子宫内膜增生病变的研究进展[J/CD]. 中华妇幼临床医学杂志(电子版)2018, 14(4): 470-476. DOI: 10.3877/cma.j.issn.1673-5250.2018.04.016.
[7]
徐洁颖,陈子江,杜艳芝. 肠道菌群与多囊卵巢综合征发病关系的研究进展[J]. 上海交通大学学报(医学版), 201636(8): 1250-1254. DOI: 10.3969/j.issn.1674-8115.2016.08.028.
[8]
田小英,侯丽辉,葛军,等. 多囊卵巢综合征和代谢综合征的关系及其预防与治疗进展[J/CD]. 中华妇幼临床医学杂志(电子版)201511(2):258-260. DOI: 10.3877/cma.j.issn.1673-5250.2015.02.024.
[9]
Guo Y, Qi Y, Yang X, et al. Association between polycystic ovary syndrome and gut microbiota[J]. PLoS One, 2016, 11(4): e0153196. DOI: 10.1371/journal.pone.0153196.
[10]
Thackray VG. Sex, microbes, and polycystic ovary syndrome[J]. Trends Endocrinol Metab, 2019, 30(1): 54-65. DOI: 10.1016/j.tem.2018.11.001.
[11]
Gulan T, Yeernuer T, Sui S, et al. Rat model of maternal polycystic ovary syndrome shows that exposure to androgens in utero results in dysbiosis of the intestinal microbiota and metabolic disorders of the newborn rat[J]. Med Sci Monit, 2019, 25: 9377-9391. DOI: 10.12659/MSM.918600.
[12]
Lindheim L, Bashir M, Münzker J, et al. Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): a pilot study[J]. PLoS One, 2017, 12(1): e0168390. DOI: 10.1371/journal.pone.0168390.
[13]
Antwi F, Fazylova N, Garcon MC, et al. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: a systematic review[J]. JBI Libr Syst Rev, 2012, 10(42 Suppl): 1-14. DOI: 10.11124/jbisrir-2012-248.
[14]
王淼,宋小宇,高宇,等. 性早熟女性患儿及其母亲的心理功能评估[J/CD]. 中华妇幼临床医学杂志(电子版)201915(2): 192-197. DOI: 10.3877/cma.j.issn.1673-5250.2019.02.011.
[15]
王淼,宋小宇,高宇,等. 不同剂量重组人生长激素治疗儿童中枢性性早熟的临床效果[J/CD]. 中华妇幼临床医学杂志(电子版)2019, 15(4): 437-443. DOI: 10.3877/cma.j.issn.1673-5250.2019.04.014.
[16]
Wang M, Zhang Y, Miller D, et al. Microbial reconstitution reverses early female puberty induced by maternal high-fat diet during lactation[J]. Endocrinology, 2020, 161(2): bqz041. DOI: 10.1210/endocr/bqz041.
[17]
Kang MJ, Oh YJ, Shim YS, et al. The usefulness of circulating levels of leptin, kisspeptin, and neurokinin B in obese girls with precocious puberty[J]. Gynecol Endocrinol, 2018, 34(7): 627-630. DOI: 10.1080/09513590.2017.1423467.
[18]
孙小玲,王静,孙彦欣,等. 育龄期多囊卵巢综合征患者健康促进生活方式与健康相关生活质量的相关性分析[J/CD]. 中华妇幼临床医学杂志(电子版), 2020, 16(6): 702-708. DOI: 10.3877/cma.j.issn.1673-5250.2020.06.012.
[19]
张丽娜,孙克,纪亚忠. 卵巢功能下降的评估标准及其诊治进展[J]. 第二军医大学学报2019, 40 (6): 659-663. DOI:10.16781/j.0258-879x.2019.06.0659.
[20]
Jeong SY, Kang S, Hua CS, et al. Synbiotic effects of β-glucans from cauliflower mushroom and Lactobacillus fermentum on metabolic changes and gut microbiome in estrogen-deficient rats[J]. Genes Nutr, 2017, 12: 31. DOI: 10.1186/s12263-017-0585-z.
[21]
Lewis-Barned NJ, Sutherland WH, Walker RJ, et al. Plasma cholesteryl ester fatty acid composition, insulin sensitivity, the menopause and hormone replacement therapy[J]. J Endocrinol, 2000, 165(3): 649-655. DOI: 10.1677/joe.0.1650649.
[22]
Gomez de Agüero M, Ganal-Vonarburg SC, Fuhrer T, et al. The maternal microbiota drives early postnatal innate immune development[J]. Science, 2016, 351(6279): 1296-1302. DOI: 10.1126/science.aad2571.
[23]
Weber D, Oefner PJ, Hiergeist A, et al. Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome[J]. Blood, 2015, 126(14): 1723-1728. DOI: 10.1182/blood-2015-04-638858.
[24]
Schluter J, Peled JU, Taylor BP, et al. The gut microbiota is associated with immune cell dynamics in humans[J]. Nature, 2020, 588(7837): 303-307. DOI: 10.1038/s41586-020-2971-8.
[25]
Dinan TG, Cryan JF. The microbiome-gut-brain axis in health and disease[J]. Gastroenterol Clin North Am, 2017, 46(1): 77-89. DOI: 10.1016/j.gtc.2016.09.007.
[26]
Bahrudin MF, Abdul Rani R, Tamil AM, et al. Effectiveness of sterilized symbiotic drink containing lactobacillus helveticus comparable to probiotic alone in patients with constipation-predominant irritable bowel syndrome[J]. Dig Dis Sci, 2020, 65(2): 541-549. DOI: 10.1007/s10620-019-05695-3.
[27]
Adlercreutz H, Pulkkinen MO, Hämäläinen EK, et al. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones[J]. J Steroid Biochem, 1984, 20(1): 217-229. DOI: 10.1016/0022-4731(84)90208-5.
[28]
Fayed AE. Review article: health benefits of some physiologically active ingredients and their suitability as yoghurt fortifiers[J]. J Food Sci Technol, 2015, 52(5): 2512-2521. DOI: 10.1007/s13197-014-1393-8.
[29]
Snart J, Bibiloni R, Grayson T, et al. Supplementation of the diet with high-viscosity beta-glucan results in enrichment for lactobacilli in the rat cecum[J]. Appl Environ Microbiol, 2006, 72(3): 1925-1931. DOI: 10.1128/AEM.72.3.1925-1931.2006.
[30]
Kumari A, Pal Pathak D, Asthana S. Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of lipid metabolism[J]. Int J Biol Sci, 2020, 16(13): 2308-2322. DOI: 10.7150/ijbs.44774.
[31]
Qi X, Yun C, Sun L, et al. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome[J]. Nat Med, 2019, 25(8): 1225-1233. DOI: 10.1038/s41591-019-0509-0.
[32]
Hofmann AF, Eckmann L. How bile acids confer gut mucosal protection against bacteria[J]. Proc Natl Acad Sci U S A, 2006, 103(12): 4333-4334. DOI: 10.1073/pnas.0600780103.
[1] Shuqin Zhang, Lian Chen. Diagnosis and treatment of postpartum intrauterine retained products of conception[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 493-497.
[2] Jiechun Shi, Ziyu Fan, Yan Xing. Early warning efficiency of different screening methods on cervical adenocarcinoma in situ[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 575-581.
[3] Dan Tang, Xiaoxi Yao, Bowen Yang, Shaolong Xue, Mengyao Li, Liuxing Wei, Mingrong Xi. The impact of doublecortin-like kinase 1 on the clinical characteristics of endometrioid adenocarcinoma patients[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 582-590.
[4] Yi Wei, Yuxi Zhou, Ye Yang, Xiufeng Ling, Chun Zhao. Current research status on roles of microRNA on endometrial receptivity[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(03): 266-270.
[5] Lin Lin, Simeng Tian, Yonghua Yu, Feifei Xu, Mingli Huang. Current research status on treatment of intrauterine adhesion by stem cells and their exosomes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(03): 271-275.
[6] Xin Li, Yi Wei, Juan Zhang, Juanjuan Zhang, Xiufeng Ling, Chun Zhao, Mianqiu Zhang. Influencing factors on clinical pregnancy outcomes of frozen-thaw embryo transfer cycle in women of advanced age[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(03): 276-283.
[7] Lin Yang, Rutie Yin. Current research status on etiology and treatment of patients with white lesions of vulva[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(02): 157-165.
[8] Weicong Gao, Li Li, Zhonghua Zhang, Xianghui Zhu, Suqiao Liu. Impact of impaired glucose regulation on recurrence within 2 years after modified radical surgery in patients with cervical cancer[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(02): 231-237.
[9] Yuping Li, Hui Ma, Hang Yu. Clinical efficacy of laparoscopic uterine artery ligation combined with myomectomy for the treatment of uterine fibroids[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(02): 238-244.
[10] Li Wang, Yueying Wang, Fen Zhou, Yukun Guo, Lina Wei. Current research status in effect of gonadotropin-releasing hormone antagonist on endometrial receptivity[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(06): 629-635.
[11] Likun Wei, Xuhong Zhang, Ying Luo, Fengxia Xue, Yingmei Wang, Xueru Song, Lina Tian, Yanfang Zhang, Yanxia Wang, Wenyan Tian. Malignant transformation of ovarian endometrioma and pelvic abscesses: a case report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(06): 696-702.
[12] Lixuan Chen, Peining Dou, Yang Xiao. Progress and future prospects of stem cell therapy for premature ovarian insufficiency[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2024, 14(04): 239-248.
[13] Xing Wang, Yuan Chen, , Wusman Rezi Wan Guli, Yanying Guo. Co-pathogenic genes and potential common molecular mechanisms of type 2 diabetes mellitus, obesity, nonalcoholic steatohepatitis, and polycystic ovary syndrome[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(05): 481-490.
[14] Fan Hong, Dunjin Chen, Yang Fu, Xinyue Liang, Yi Wu, Xiaoyi Wang. Clinical study of in vitro fertilization-embryo transfer pregnancy complicated with placenta previa[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(03): 176-182.
[15] Yuhua He, Huanmei Zhong, Wenhui Wang, Yongqi Shen, Yingyun Liu, Guowei Gu, Danna Chen. Analysis of metabolic indexes among patients with different polycystic ovary syndrome (PCOS)phenotypes and diagnostic efficacy of obesity-related indexes in PCOS patients complicated with metabolic syndrome[J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2024, 12(04): 212-220.
Viewed
Full text


Abstract